Later this year, the World AMR Awareness Week (18-24 November 2024) will be observed worldwide on the theme: Educate, Advocate and Act Now.... Aug 10
Initiative for Comprehensive Respiratory Care... Jun 12
According to the WHO 7 to 10% of every 100 hospitalized patients, 7% in high-income countries, and 10% in low-middle-income countries acquire ... Oct 23
Manipal HealthMap highlighted that the acquisition will expand its footprint by adding 23 new centres to its Manipal TRUtest network. This network, post-acquisition, will ... Oct 19
Rivaara Labs has received Rs 60 Crores from Amicus Capital and Kotak Investment. The new funds will be used to speed the development of test ... Nov 09
Dilip Patil and Dr Rajvi Mehta from TRIVECTOR BIOMED talked about their product - FAR UVC Technology or Light Sanitiser to protect against coronavirus and other ... Feb 22
Karishma Shah and Dr. Aditya Sharma give important insights into urinary health. They inform that urinary problems are common in women than in men. They ... Dec 16
All about Russia’s Sputnik vaccine ... Sep 21
Experts trash lab leak theory ... Jul 08
Molnupiravir, the antiviral drug was initially developed for the treatment of influenza and is repurposed to completely suppress the COVID virus transmission within 24 hours.... Jun 11
The platform will be free for researchers and non-profits to use worldwide... May 19
... May 14
Sputnik V is the world's first registered vaccine against Covid-19 based on the human adenoviral vector platform.... Feb 20
New malaria mosquito emerges in African cities: Experts are worried... Jan 29
Sputnik V phase 3 trials cleared by the government... Jan 16
SIREN research study came up with the post-vaccine results in UK... Jan 14
Top ten Indian small cap pharma stocks Jan 2021... Jan 08
The drugs discovery program is for servicing the US$111.2B global Metastatic Cancer market... Dec 31
Feluda, Jatayu and Topshe helps to scale up the war against Coronavirus... Dec 21
Research on a novel nasal spray therapy, INNA-051, which has been shown to reduce COVID-19 viral replication by up to 96 percent in ... Dec 18
... Dec 08
CPI-818, an oral interleukin-2-inducible T-cell kinase inhibitor, is well-tolerated and active in patients with T-cell lymphoma... Dec 07
This will be a multicenter and randomized controlled study, which will include a safety and immunogenicity study.... Dec 02
A study of measles-mumps-rubella titers and SARS-CoV-2 infection severity was published in mBio, the open-access journal of the American Society ... Nov 21
Collaboration with the Bill & Melinda Gates Foundation Seeks to Bring Forward a New HIV Prevention Option with Focus on Women... Nov 16
-Advertisements-
.jpeg)
Friday, November 22, 2024
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)